[go: up one dir, main page]

IL91843A0 - Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids - Google Patents

Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids

Info

Publication number
IL91843A0
IL91843A0 IL91843A IL9184389A IL91843A0 IL 91843 A0 IL91843 A0 IL 91843A0 IL 91843 A IL91843 A IL 91843A IL 9184389 A IL9184389 A IL 9184389A IL 91843 A0 IL91843 A0 IL 91843A0
Authority
IL
Israel
Prior art keywords
aids
prophylaxis
diagnosis
therapy
peptides useful
Prior art date
Application number
IL91843A
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of IL91843A0 publication Critical patent/IL91843A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL91843A 1988-10-03 1989-09-29 Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids IL91843A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25294988A 1988-10-03 1988-10-03
US35954389A 1989-06-01 1989-06-01
US40766389A 1989-09-19 1989-09-19

Publications (1)

Publication Number Publication Date
IL91843A0 true IL91843A0 (en) 1990-06-10

Family

ID=27400615

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91843A IL91843A0 (en) 1988-10-03 1989-09-29 Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids

Country Status (10)

Country Link
EP (1) EP0436634A1 (en)
JP (1) JPH04502760A (en)
KR (1) KR900701836A (en)
AU (1) AU640619B2 (en)
DK (1) DK57391A (en)
FI (1) FI911574A0 (en)
IL (1) IL91843A0 (en)
NZ (1) NZ230855A (en)
PT (1) PT91881A (en)
WO (1) WO1990003984A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2627798A (en) * 1951-08-27 1953-02-10 William T Graham Clamp for vibrating shank plows
US2712781A (en) * 1952-03-06 1955-07-12 Glencoe Mfg Company Mounting for earth tiller
US2739518A (en) * 1952-04-19 1956-03-27 Glencoe Mfg Company Shank holder
US2775181A (en) * 1953-08-17 1956-12-25 Int Harvester Co Spring mounted tool shank
US3461971A (en) * 1966-07-05 1969-08-19 American Tractor Equip Corp Vyba mount
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
PT94276A (en) * 1989-06-05 1991-02-08 MONOCLONAL ANTIBODY ABLE TO NEUTRALIZ THE HIV PROTOTYPE MN
EP0448095A1 (en) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections
WO1991019011A1 (en) * 1990-06-08 1991-12-12 Repligen Corporation Immunoassays for anti-hiv-1 antibodies
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
JP2989862B2 (en) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 Monoclonal antibody
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
CA2047033A1 (en) * 1990-07-19 1992-01-20 Elizabeth E. Sugg Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
IT1244529B (en) * 1991-01-30 1994-07-15 Ist Superiore Sanita SYNTHETIC PEPTIDES SUITABLE TO ENHANCE THE INFECTIVITY OF THE HIV-1 VIRUS
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
EP0536352B1 (en) * 1991-04-02 2003-12-17 Albert Einstein College Of Medicine Of Yeshiva University Therapeutic and preventive vaccines for hiv
JPH0570493A (en) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst Human immunodeficiency virus (HIV) related immunization preparation
WO1994004574A1 (en) * 1991-08-22 1994-03-03 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
AU678371B2 (en) 1992-06-18 1997-05-29 Creagen, Inc. Combinatorial polypeptide antigens
EP0588750A3 (en) * 1992-08-05 1995-01-11 Cigb Process for the production of recombinant polypeptides containing epitopes derived from different HIV isolates, their use as immunogens and for the detection of antibodies against HIV.
FR2694938B1 (en) * 1992-08-10 1996-11-15 Zagury Jean Francois NOVEL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, ANTI-IDIOTYPIC ANTIBODIES, APPLICATION AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM.
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
US5563032A (en) * 1992-10-21 1996-10-08 The United States Of America As Represented By The Department Of Health And Human Services Mosaic polypeptide and methods for detecting the hepatitis E virus
AU6136694A (en) * 1993-02-12 1994-08-29 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
WO1994020632A1 (en) * 1993-03-11 1994-09-15 Juridical Foundation The Chemo-Sero-Therapeutic R Esearch Insitute Anti-hiv monoclonal antibody
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US6080429A (en) * 1993-10-25 2000-06-27 Genentech, Inc. Method for drying microspheres
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
US6585979B1 (en) * 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ATE384795T1 (en) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic MODIFIED HIV ENV POLYPEPTIDES
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
EP1141313A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
JP2003509035A (en) * 1999-09-16 2003-03-11 ザイコス インク． Nucleic acids encoding polyepitope polypeptides
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP1427806A4 (en) 2001-08-31 2006-04-26 Chiron Corp Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
KR100466382B1 (en) * 2002-01-08 2005-01-14 주식회사 엘지생명과학 Recombinant combo protein fused in HIV type-1 and -2, manufacturing method thereof, vector, transformant and diagnostic kit thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108022T1 (en) * 1985-10-24 1994-07-15 Southwest Found Biomed Res SYNTHETIC PEPTIDES AND THEIR USE IN DIAGNOSIS AND VACCINATION FOR AIDS AND ARC.
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
AU7786387A (en) * 1986-07-21 1988-02-10 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
JPH0762031B2 (en) * 1986-12-30 1995-07-05 アメリカ合衆国 Synthetic peptides that induce cell-mediated immunity to AIDS virus and AIDS virus proteins
JP2520464B2 (en) * 1987-05-29 1996-07-31 タノツクス・バイオシステムズ・インコーポレーテツド Monoclonal antibody that neutralizes HIV-1
FR2619012B1 (en) * 1987-08-07 1989-12-22 Pasteur Institut VACCINES IN WHICH THE CHARACTERISTIC EPITOPE IS INCORPORATED IN A PROTEIN OF PICORNAVIRUS, ESPECIALLY POLIOVIRUS
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
NL8702403A (en) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund OLIGOPEPTIDES AND THEIR USE FOR DIAGNOSTIC AND VACCINATION PURPOSES FOR AIDS AND ARC.

Also Published As

Publication number Publication date
EP0436634A1 (en) 1991-07-17
DK57391D0 (en) 1991-04-02
KR900701836A (en) 1990-12-04
JPH04502760A (en) 1992-05-21
AU4403689A (en) 1990-05-01
AU640619B2 (en) 1993-09-02
WO1990003984A1 (en) 1990-04-19
PT91881A (en) 1990-04-30
FI911574A7 (en) 1991-04-02
DK57391A (en) 1991-05-29
NZ230855A (en) 1994-10-26
FI911574A0 (en) 1991-04-02

Similar Documents

Publication Publication Date Title
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
GB2221300B (en) Enzyme electrodes and improvements in the manufacture thereof
AU617088B2 (en) Peptides involved in the pathogenesis of hiv infection
AU6399786A (en) Polypeptides used in the diagnosis and therapy of AIDS
NZ224046A (en) Hiv antigenic peptide fragments and their use
GB2213823B (en) Synthetic peptides for use in the diagnosis and prevention of influenza virus infection
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
GB2203740B (en) Novel peptides, their preparation and use
AU6428890A (en) Therapeutic peptides and proteins
NZ227594A (en) Human interleukin-1alpha and preparations thereof
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
IL86796A0 (en) Peptide derivatives,their preparation and their use
ZA888701B (en) Expression of hiv proteins in e.coli and s. cerevisiae
ZA897509B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
AU2738088A (en) Soluble recombinant fce-receptor, the preparation and the use thereof
EG18799A (en) Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
GR900300003T1 (en) 3-aminodihydrothiophene-2-one peptide derivatives, processes for the preparation and therapeutic use
AU4096889A (en) The use of lactam derivatives in the treatment of depression
ZA889506B (en) Soluble recombinant fce-receptor,the preparation and the use thereof
IL89993A0 (en) Expression of the hiv 24kda gag protein in methylotrophic yeasts
ZA869678B (en) Use of oligopeptides in the treatment of viral infections
IL86983A0 (en) Pyridylthio-,pyridylsulfinyl-and pyridylsulfonyl-phenyl-thioureas,isothioureas and-carbodiimides,their preparation and use in the control of pests
IE891349L (en) EXPRESSION OF THE HIV kDa GAG PROTEIN IN YEAST
SG130694G (en) Peptide fragments of hiv and their use in vaccines and diagnosis
AU2489688A (en) Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc